Canada · Health Canada Drug Product Database
VIMOVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84676
- DIN
- 02361701
- Form
- Tablet (Immediate- And Delayed-Release)
- Company as listed by source
- XEDITON PHARMACEUTICALS INC
- Source status
- Marketed (2022-02-28)
- Source last updated
- 2026-08-17
Source-listed ingredients
- NAPROXEN — 375 MG
- ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) — 20 MG
These values do not establish equivalence or a dose recommendation.
Packages
- 60
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →